DrugPatentWatch Database Preview
Virtus Pharm Company Profile
Email this page to a colleague
» See Plans and PricingWhat is the competitive landscape for VIRTUS PHARM, and what generic and branded alternatives to VIRTUS PHARM drugs are available?
VIRTUS PHARM has eighteen approved drugs.
Summary for Virtus Pharm
| US Patents: | 0 |
| Tradenames: | 12 |
| Ingredients: | 12 |
| NDAs: | 18 |
Drugs and US Patents for Virtus Pharm
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Virtus Pharm | PALONOSETRON HYDROCHLORIDE | palonosetron hydrochloride | INJECTABLE;INTRAVENOUS | 209287-001 | Sep 19, 2018 | AP | RX | No | No | Start Trial | Start Trial | ||||
| Virtus Pharms | LEVETIRACETAM | levetiracetam | TABLET, EXTENDED RELEASE;ORAL | 091291-002 | Sep 12, 2011 | DISCN | No | No | Start Trial | Start Trial | |||||
| Virtus Pharms | NALOXONE HYDROCHLORIDE | naloxone hydrochloride | INJECTABLE;INJECTION | 207846-001 | Dec 17, 2018 | DISCN | No | No | Start Trial | Start Trial | |||||
| Virtus Pharms | PROMETRIUM | progesterone | CAPSULE;ORAL | 019781-002 | Oct 15, 1999 | AB | RX | Yes | Yes | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
